Compare ARLP & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARLP | PLSE |
|---|---|---|
| Founded | 1971 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Coal Mining | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.6B |
| IPO Year | 1999 | 2015 |
| Metric | ARLP | PLSE |
|---|---|---|
| Price | $26.53 | $53.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $30.00 | $22.00 |
| AVG Volume (30 Days) | 254.9K | ★ 531.6K |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 9.00% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,002,857,000.00 | N/A |
| Revenue This Year | $2.20 | $840.00 |
| Revenue Next Year | $3.57 | $287.54 |
| P/E Ratio | $10.68 | ★ N/A |
| Revenue Growth | ★ 11.50 | N/A |
| 52 Week Low | $22.72 | $12.56 |
| 52 Week High | $29.45 | $58.90 |
| Indicator | ARLP | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 64.37 | 67.23 |
| Support Level | $24.35 | $24.27 |
| Resistance Level | $26.87 | N/A |
| Average True Range (ATR) | 0.39 | 3.85 |
| MACD | 0.03 | -0.21 |
| Stochastic Oscillator | 90.82 | 63.42 |
Alliance Resource Partners LP operates as a coal mining company based in the United States. It has four segments: Illinois Basin, Appalachia, Oil & Gas Royalties, and Coal Royalties. The Illinois Basin comprises underground mining complexes in Illinois, Indiana, Kentucky, Maryland, and West Virginia. The Appalachia segment comprises the Mettiki mining complex, the Tunnel Ridge mining complex, and the MC Mining complex. The Oil & Gas Royalties has oil & gas mineral interests held by AR Midland and AllDale I & II, and includes Alliance Minerals' equity interests in both AllDale III and Cavalier Minerals. The Coal Royalties have included coal mineral reserves and resources owned or leased by Alliance Resource Properties.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.